InvestorsHub Logo
Followers 59
Posts 4696
Boards Moderated 0
Alias Born 04/27/2009

Re: None

Wednesday, 05/20/2015 12:20:37 PM

Wednesday, May 20, 2015 12:20:37 PM

Post# of 20775
Posted by Dew Dilegence on the Bio Tec Values brd.?? JNJ’s Husseini Manji is talking about the Bapineuzumab follow-on compound.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.